Evidence map›Paper›PMID 42250518›Full record

ReviewCurrent opinion in structural biology2026

Transcription factors as drivers of 3D enhancer-promoter interactions.

Nicholas G Aboreden, Gerd A Blobel

Abstract readReview
In one paragraph

Review in Current opinion in structural biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nicholas G AboredenDivision of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Gerd A BlobelDivision of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: blobel@chop.edu.

Funding

Transcriptional Networks Controlling Erythroid DifferentiationR01DK054937 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Gerd A Blobel · 1999 to 2026
$12.8M
Engineering and Imaging 3D genome structure-function dynamics across time scalesU01DK127405 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BLOBEL, GERD A, PHILLIPS-CREMINS, JENNIFER ELIZABETH · 2020 to 2024
$5.7M
Roles of CBP &PCAF During Hematopoietic DifferentiationR01DK058044 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI BLOBEL, GERD A · 2002 to 2023
$4.5M
Investigating the role of Ldb1 in chromatin architecture and transcription during erythroid cell state transitionsF31DK136200 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI ABOREDEN, NICHOLAS · 2024 to 2024
$49k
NIDDK NIH HHS F31 DK136200NIDDK NIH HHS R01 DK054937NIDDK NIH HHS R01 DK058044NIDDK NIH HHS U01 DK127405
6 · The paper itself

Abstract

The molecular basis for specific pairing between transcriptional enhancers and promoters remains a highly active area of investigation, even over four decades after enhancers were first discovered. Numerous studies have explored general mechanisms such as those involving the cohesin/CTCF system and the core transcriptional machinery, including RNA polymerase 2, but these fail to account for the specificity of gene expression across cell types, maturation stages, and cell cycle intervals. Genetic loss of tissue-specific transcription factors provided early insights, but the findings were fraught with potentially confounding secondary effects. The advent of tools permitting rapid protein degradation has changed that. Here we discuss recent studies of illustrative mammalian transcription (co-) factors with architectural roles that contribute to enhancer-promoter communication, and contextualize their functions within generic chromatin-organizing principles.

Indexed as

Enhancer Elements, GeneticPromoter Regions, GeneticTranscription FactorsAnimalsChromatinHumansChromatinTranscription Factors

Identifiers

PMID42250518
PMCPMC13347951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.